Breaking News
October 17, 2018 - Modeling Non-Numerical Data in Systems Biology
October 17, 2018 - Research aims to address health disparities in African-American men
October 17, 2018 - Human and cattle decoys trap outdoor-biting mosquitoes in malaria endemic regions
October 17, 2018 - High Circulating Prolactin Level Inversely Linked to T2DM Risk
October 17, 2018 - Study finds gene variant predisposes people to both Type 2 diabetes and low body weight
October 17, 2018 - Network of doctors identify the cause of 31 new conditions
October 17, 2018 - Notable improvement in brain cancer survival among younger patients but not much for elderly
October 17, 2018 - Scientists shed light on roles of transcription factors, TP63 and SOX2, in squamous cell carcinoma
October 17, 2018 - Costs of Medicare Diabetes Prevention Program may be higher than expected reimbursement
October 17, 2018 - Misuse of prescription opioids or benzodiazepines associated with suicidal thoughts
October 17, 2018 - New research seeks to address sex disparities in women’s health
October 17, 2018 - C-Section Rates Have Nearly Doubled Since 2000: Study
October 17, 2018 - Talking to Your Kids About STDs
October 17, 2018 - New classification of periodontal and peri-implant diseases and conditions
October 17, 2018 - Herbert D. Kleber, Pioneer in Addiction Treatment, Dies at 84
October 17, 2018 - Health effects of smoke-filled atmosphere
October 17, 2018 - Down syndrome may hold important clues to onset of Alzheimer’s disease
October 17, 2018 - A special report on US’ aging societies
October 17, 2018 - Birth mode may have acute effects on neurodevelopment, study suggests
October 17, 2018 - Global health innovation system fails to deliver affordable treatments to patients, says report
October 17, 2018 - Simple, inexpensive test quickly detects antibiotic-resistant ‘superbugs’
October 17, 2018 - New drugs could reduce risk of heart disease when added to statins
October 17, 2018 - Visible and valued: Stanford Medicine’s first-ever LGBTQ+ Forum
October 17, 2018 - HVP vaccination not linked with rise in teen risky sex
October 17, 2018 - Potential ‘early warning markers’ for sepsis discovered
October 17, 2018 - Who knew? Life begins (again) at 65
October 17, 2018 - Application of blood pressure guidelines ups treatment
October 17, 2018 - Stanford researchers find that small molecule may help treat enzyme deficiency
October 17, 2018 - Speed Cameras Save Money and Lives in New York City
October 17, 2018 - Men who conform to ‘the man box’ more likely to consider suicide and violence
October 17, 2018 - Researchers aim to create more authentic organoids for drug testing, transplantation
October 16, 2018 - New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies
October 16, 2018 - Age-related estrogen increase may be the culprit behind inguinal hernias in men
October 16, 2018 - Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
October 16, 2018 - Researchers uncover new role of TIP60 protein in controlling tumour formation
October 16, 2018 - Behind the scenes of a lifesaving heart surgery
October 16, 2018 - ‘To See the Suffering’
October 16, 2018 - Drinking concentrated rosemary extract can boost memory by up to 15%, shows research
October 16, 2018 - Medicare Advantage riding high as new insurers flock to sell to seniors
October 16, 2018 - NHS tackles prescription fraud to save millions
October 16, 2018 - New molecular switch may help develop sophisticated photomedications
October 16, 2018 - Improving access to behavioral health screenings for pregnant and postpartum women
October 16, 2018 - Health Highlights: Oct. 12, 2018
October 16, 2018 - Study holds promise for new pediatric brain tumor treatment
October 16, 2018 - Patient advocate uses MRI scans to create art and spark conversations about life with illness
October 16, 2018 - Fish oil based diets may suppress growth and spread of breast cancer cells
October 16, 2018 - Number of VHA facilities offering acupuncture has increased rapidly
October 16, 2018 - Influential Leapfrog Group jumps in to rate 5,600 surgery centers
October 16, 2018 - HIV-infected infants more likely to acquire congenital cytomegalovirus infection
October 16, 2018 - Study pinpoints new marker that can predict Crohn’s disease subtype
October 16, 2018 - Simple procedure could be efficacious intervention for failed back surgery
October 16, 2018 - New research identifies modifiable dementia risk factor in elderly people
October 16, 2018 - Zebrafish study uncovers molecular ‘brake’ that helps control eye lens development
October 16, 2018 - Overlapping copy number variations underlie autism and schizophrenia in Japanese patients
October 16, 2018 - Early menopause and diabetes may reduce life expectancy
October 16, 2018 - Majority of Americans’ ancestry can be traced through existing DNA databases
October 16, 2018 - Patients coerced into mental health care less likely to perceive treatment as effective
October 16, 2018 - Healthy elders can consume walnuts without having negative impact on weight gain, finds study
October 16, 2018 - Interactive robot helps older people exercise and detects underlying health problems
October 16, 2018 - What you need to know about autism spectrum disorder
October 16, 2018 - Antidepressants can be used to treat Alzheimer’s disease
October 16, 2018 - Study uncovers important role of PRMT1 in dilated cardiomyopathy
October 16, 2018 - Nutritional quality of breakfast linked to cardiovascular and metabolic risk factors in children
October 16, 2018 - Study uses novel approach to investigate genetic origins of mental illnesses
October 16, 2018 - Scientists develop dual anthrax-plague vaccine
October 16, 2018 - Poor Outcomes for Hispanic Infants With Congenital Heart Dz
October 16, 2018 - Global study finds youngest in class more likely to be diagnosed with ADHD
October 16, 2018 - Researchers sequence two selfish genes in the fungus Neurospora intermedia
October 16, 2018 - Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis
October 16, 2018 - Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration
October 16, 2018 - Researchers create open access database on healthy immunity
October 16, 2018 - Rice University chemist wins big award to study small surfaces
October 16, 2018 - Study finds 43% drop in stroke rate
October 16, 2018 - Researchers identify basic relationships of cell cycle and cellular senescence in the placenta
October 16, 2018 - UA professor receives NSF grant to develop antifouling materials for medical implants
October 16, 2018 - Obesity Doubles Odds for Colon Cancer in Younger Women
October 16, 2018 - Adults with ADHD not constrained in creativity
October 16, 2018 - Raising visibility for people and students with chronic illness and disability
October 16, 2018 - Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis
October 16, 2018 - Only 59% of young adults undergoing surgery are fluid responsive
Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear

Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear

image_pdfDownload PDFimage_print

About one decade after its first benefit assessment of negative pressure wound therapy (NPWT), the German Institute for Quality and Efficiency in Health Care (IQWiG) is reassessing this treatment method. However, then as now, its benefit and harm are unclear. Whereas only few studies with very limited informative value were available in 2006, over 100 clinical comparisons with several thousands of patients have been conducted since. But results have been published for only some of these studies, as not only the manufacturers of the medical devices used, but also researchers, are concealing data, thus violating ethical and scientific standards. Assessing the benefit and harm of the treatment solely on the basis of the published data could have entailed a seriously biased result. Hence, there is still no valid basis for the assessment of the benefit and harm of this treatment.

The current report deals with NPWT for wounds healing by secondary intention; wounds healing by primary intention are the subject of a second benefit assessment. In NPWT, negative pressure in the wound is used to promote wound healing, and to accelerate the healing of large wounds in particular.

Over 100 studies with several thousands of participants

The Institute has now found that a large number of further randomized controlled trials (RCTs) comparing NPWT with standard treatment have been completed since its last report. There are currently over 100 studies involving several thousands of patients, which is an unusually large number for a non-drug intervention. One would think that this would be a good starting point for a benefit assessment.

Publication bias: positive effect often overestimated

The inclusion of the results of all studies in the assessment is indispensable to be able to draw reliable conclusions. The use of only published data could lead to an overestimation of the positive effects of a medical intervention, because it is known from research that studies with “unfavorable” results are usually the ones that remain in the file drawer or are published only years later. This is referred to as “publication bias”.

For this reason, IQWiG not only conducts searches in databases or registries, but also sends requests to manufacturers and authors who have reported studies in journals, trial registries or presentations, for example. “Detective work” is sometimes required to identify studies.

Agreement with sponsors to facilitate cooperation

To be able to also use the results from studies sponsored by manufacturers as completely as possible and to facilitate cooperation, the Institutes regularly offers a contract to such sponsors, which has advantages for both sides: Confidential information such as confidential business and commercial information remains protected in any case. In return, the manufacturer agrees to submit the complete data on all published and unpublished studies. IQWiG may use and publish the results and the underlying methods.

The Institute has concluded such a contract with several manufacturers of NPWT systems. This is a comprehensive agreement, i.e. irrespective of a division of the commission by type of wound (primary, secondary).

Data missing for a large proportion of relevant studies

Many of the newly searched RCTs recorded and reported usable data on so-called patient-relevant outcomes such as mortality, wound closure, pain, complications (of treatment), length of hospital stay, or need of long-term care, and were therefore relevant for the assessment. However, there were also a large number of studies for which the results were not available, although the Institute had repeatedly requested information from the respective study investigators.

KCI does not comply with the contract

Despite several requests, the US-based manufacturer KCI Medical Devices (Acelity) provided neither a complete overview nor complete clinical study reports on all the studies for which the company is responsible. As a result, data were incomplete for half of all participants (842 of 1681). The IQWiG researchers therefore could not consider these studies for their benefit assessment of NPWT.

Standards violated also by researchers

However, there are also gaps in the remaining studies, most of them so-called investigator-initiated trials (IITs), which were, for example, initiated by university-based researchers: Regarding secondary wound healing, usable study results were missing for at least 1703 of 4251 participants in total, corresponding to 40%. Since this magnitude impedes a meaningful interpretation of the results, here too, the Institute dispensed with an assessment of benefit and harm.

Nothing is known about the researchers’ motives. Their own research interests or dependencies might play a role. It is obvious at least for some of the IITs that even though the manufacturers did not act as sponsors, they were involved indirectly, e.g. by granting scholarships or by supporting the analysis of the data and the production of manuscripts (medical writing).

Concealing data harms patients and physicians

Stefan Sauerland, Head of the Department of Non-Drug Interventions, notes with frustration: “The evidence base was meager when we conducted our first assessments. Now there are studies with several thousands of patients, but we still cannot say whether NPWT is better, equivalent, or possibly even worse than conventional wound treatment.”

The reason is that both companies and researchers are concealing data. “This violates ethical and scientific standards”, says Stefan Sauerland. “And they harm patients and physicians as well as the community of insured citizens, which to me, as a physician and researcher, is very disconcerting.”

Registration and publication of the results must be mandatory

NPWT is an example showing that further legal regulations are required, also for studies on non-drug interventions and medical devices. Unlike in other countries such as the United States, medical devices in Europe are not subject to a central approval process. A certification by “designated bodies”, which are private sector organizations, is sufficient to launch a medical device. In many cases, clinical studies have not been necessary for this, even though Europe’s Medical Device Directive is a considerable improvement for the requirements of a clinical assessment. In addition, in Germany, almost all new non-drug interventions can be used in hospitals and be reimbursed by statutory health insurance funds without prior assessment of their benefit or harm. A positive benefit assessment is only required for the outpatient sector.

New legislation would have to stipulate the registration of studies on non-drug interventions or medical devices before their start and the timely publication of their results. “More progress has been made in drug studies”, says Stefan Sauerland. An EU directive and the German Act on the Reform of the Market for Medicinal Products (AMNOG) have notably increased transparency regarding drugs. Stefan Sauerland is convinced: “Without similar regulations, reliable data on interventions such as NPWT will still not be available in 10 years’ time.”

Source:

https://www.iqwig.de/en/press/press-releases/negative-pressure-wound-therapy-violation-of-ethical-and-scientific-standards.10021.html

Tagged with:

About author

Related Articles